Sotera Health price target raised to $20 from $18 at Citi
The Fly

Sotera Health price target raised to $20 from $18 at Citi

Citi raised the firm’s price target on Sotera Health (SHC) to $20 from $18 and keeps a Buy rating on the shares. The firm cites the “solid” Q3 results for the target increase. It remains constructive on Sotera’s long-term opportunity while acknowledging the potential risks associated with the litigation.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App